Determination of structural, spectral, electronic and biological properties of Tosufloxacin (cas 108138-46-1) boron complexes and investigation of substituent effect
-
Add time:08/25/2019 Source:sciencedirect.com
Quantum chemical calculations are performed over some boron complexes with Tosufloxacin (cas 108138-46-1). Boron complex with fluorine atoms are optimized at HF/6-31+G(d), B3LYP/6-31+G(d) and M062X/6-31+G(d) level and the best level is determined by comparison of experimental and calculated results. The other complexes are optimized by using the best level. Structural properties, IR and NMR spectrum are examined in detail. Biological activities of mentioned complexes are investigated by some quantum chemical descriptors and molecular docking analyses. As results, it is found that boron complex with fluorine atoms coordinated to boron atom is the best candidate for anticancer drug. Additionally, NLO properties of mentioned complexes are investigated and complex (2) is found as the best candidate for NLO applications.
We also recommend Trading Suppliers and Manufacturers of Tosufloxacin (cas 108138-46-1). Pls Click Website Link as below: cas 108138-46-1 suppliers
Prev:Analysis of the spectroscopic characteristics on the binding interaction between Tosufloxacin (cas 108138-46-1) and bovine lactoferrin
Next:Pharmacodynamic evaluation of Tosufloxacin (cas 108138-46-1) against Streptococcus pneumoniae in an in vitro model simulating serum concentration) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Antibacterial activity of Tosufloxacin (cas 108138-46-1) against major organisms detected from patients with respiratory or otorhinological infections: comparison with the results obtained from organisms isolated about 10 years ago08/27/2019
- Pharmacodynamic evaluation of Tosufloxacin (cas 108138-46-1) against Streptococcus pneumoniae in an in vitro model simulating serum concentration08/26/2019
- Analysis of the spectroscopic characteristics on the binding interaction between Tosufloxacin (cas 108138-46-1) and bovine lactoferrin08/24/2019
- Short CommunicationKilling kinetics of minocycline, doxycycline and Tosufloxacin (cas 108138-46-1) against macrolide-resistant Mycoplasma pneumoniae08/23/2019
- Emergence of Haemophilus influenzae with low susceptibility to quinolones and persistence in Tosufloxacin (cas 108138-46-1) treatment08/22/2019
-
Health and Chemical more >
-
Related Products